XT-0528

Xenthera, Inc. · Phase 1 active Small molecule

At a glance

Generic name	XT-0528
Sponsor	Xenthera, Inc.
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Subjects With Advanced or Metastatic Solid Tumor Malignancies (PHASE1)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

XT-0528 CI brief — competitive landscape report
XT-0528 updates RSS · CI watch RSS
Xenthera, Inc. portfolio CI